Watch Ticker

SAB Biotherapeutics, Inc. Common Stock

Go to SAB Biotherapeutics, Inc. Common Stock Website

$2.39

0.11 (4.82%)

Live

Previous Close

$2.28

Day Range

$2.22 - $2.3929

Previous Day Range

$2.1201 - $2.345

Market Cap

$20.7 million USD

Day Vol.

118742

Previous Day Vol.

123778

Currency

USD

Primary Exchange

Nasdaq

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, witho...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

SAB BIO, a clinical-stage biopharmaceutical company, reported financial results for Q1 2025. The company made progress on its type 1 diabetes program, including positive Phase 1 data for its lead candidate SAB-142. SAB BIO also achieved manufacturing milestones and saw a decrease in R&D and G&A expenses.

Related tickers: SABS, SABSW.

Read Full Article

N/A - SAB BIO to Participate in Upcoming Investor Conferences

SAB BIO, a clinical-stage biopharmaceutical company, announced its participation in upcoming investor conferences to discuss its lead asset, SAB-142, which targets type 1 diabetes with a disease-modifying approach.

Related tickers: SABS, SABSW.

Read Full Article

Trending Tickers

Please sign in to view